Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.54 |
| ▸ | PPARG | P37231 | 5/20 | 0.50 |
| ▸ | PPARD | Q03181 | 5/20 | 0.50 |
| ▸ | PPARA | Q07869 | 4/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.48 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | PDIA6 | Q15084 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 2/20 | 0.46 |
| ▸ | THRA | P10827 | 2/20 | 0.44 |
| ▸ | THRB | P10828 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | NR5A1 | Q13285 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30630148 | 1.00 | ESR1 (0.54) | ESR1PPARGPPARDPPARAMAPT | |
| SCHEMBL14015789 | 0.94 | ESR1 (0.55) | ESR1PPARGPPARDPPARAPDIA6 | |
| SCHEMBL11244540 | 0.94 | ESR1 (0.55) | ESR1PPARGPPARDPPARAPDIA6 | |
| SCHEMBL14015794 | 0.94 | ESR1 (0.55) | ESR1PPARGPPARDPPARAPDIA6 | |
| SCHEMBL28832127 | 0.92 | PPARG (0.47) | ESR1PPARGPPARDPPARAMAPT | |
| SCHEMBL12954611 | 0.85 | CYP2D6 (0.54) | ESR1PPARGPPARDPPARAKDM4E | |
| SCHEMBL12301283 | 0.85 | ESR1 (0.50) | ESR1MAPTTHRATHRBALDH1A1 | |
| SCHEMBL10717739 | 0.84 | TSHR (0.46) | ESR1MAPTKDM4ECYP1A2CYP2C19 | |
| SCHEMBL12428 | 0.84 | SMN1; SMN2 (0.54) | ESR1MAPTKDM4ETHRBTDP1 | |
| SCHEMBL28032047 | 0.84 | CARM1 (0.44) | ESR1PPARGPPARDPPARAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4303277-A1 | ANTIFOULING COATING COMPOSITION | Nitto Kasei Co., Ltd. (JP) | 2024-01-10 | — | — | EP | disclosed |
| CN-116981742-A | Antifouling coating composition | 日东化成株式会社 | 2023-10-31 | — | — | CN | disclosed |
| WO-2022186143-A1 | ANTIFOULING COATING COMPOSITION | 日東化成株式会社 | 2022-09-09 | — | — | WO | disclosed |
| US-20170336728-A1 | ULTRAVIOLET CURABLE LIQUID COMPOSITION, ULTRAVIOLET CURING INKJET INK, ULTRAVIOLET CURING WET ELECTROPHOTOGRAPHIC LIQUID DEVELOPER, ULTRAVIOLET CURING ELECTROSTATIC INKJET INK, AND IMAGE FORMING METHOD USING THEREOF | CANON KABUSHIKI KAISHA (JP) | 2017-11-23 | — | — | US | disclosed |
| CN-105820069-A | N-{4-[3-(3-bromo-phenyl)-ureidomethyl]-2,5-dibutoxy-phenyl}-methanesulfonamide new compound and preparation method and application thereof | 齐鲁工业大学 | 2016-08-03 | — | — | CN | disclosed |
| CN-105820070-A | N-{4-[3-(3-bromo-phenyl)-ureidomethyl]-2,5-dimethoxy-phenyl}-methanesulfonamide new compound, new intermediate, preparation method and application | 齐鲁工业大学 | 2016-08-03 | — | — | CN | disclosed |
| US-9109081-B2 | Method for producing aromatic polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-08-18 | — | — | US | disclosed |
| US-9109081-B2 | Method for producing aromatic polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-08-18 | — | — | US | disclosed |
| US-20100144999-A1 | METHOD FOR PRODUCING AROMATIC POLYMER | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20100144999-A1 | METHOD FOR PRODUCING AROMATIC POLYMER | SUMITOMO CHEMICAL COMPANY, LTD. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20080090779-A1 | ANTIALLERGIC AGENTS | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2008-04-17 | — | — | US | disclosed |
| US-20070185059-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185059-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185110-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| US-20070185110-A1 | Antiallergic agents | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-08-09 | — | — | US | disclosed |
| CN-1920667-A | Photosensitive slurry | SUMITOMO CHEMICAL CO (JP) | 2007-02-28 | — | — | CN | disclosed |
| US-20070042997-A1 | Medicament for treatment of dermal pigmentation | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-20070042997-A1 | Medicament for treatment of dermal pigmentation | INSTITUTE OF MEDICINAL MOLECULAR DESIGN, INC. (JP) | 2007-02-22 | — | — | US | disclosed |
| US-20040259019-A1 | Positive photosensitive composition | SUMITOMO CHEMICAL COMPANY, LIMITED | 2004-12-23 | — | — | US | disclosed |
| CN-1525248-A | Positivity light-sensitive composition | 住友化学工业株式会社 | 2004-09-01 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080090779-A1 | ANTIALLERGIC AGENTS | NAT1, EPX, HRH2 | ESR1 211/4885PPARG 754/4885PPARD 2325/4885 |
| US-20070185110-A1 | Antiallergic agents | NAT1, EPX, AHR | ESR1 273/4885PPARG 764/4885PPARD 2254/4885 |
| US-20070185059-A1 | Antiallergic agents | NAT1, EPX, AHR | ESR1 204/4885PPARG 723/4885PPARD 2166/4885 |
| US-20070042997-A1 | Medicament for treatment of dermal pigmentation | TYR, XDH, XPA | ESR1 3695/4885PPARG 45/4885PPARD 759/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.